Patient-Reported Outcomes of Long-Term Upadacitinib Use in Patients with Rheumatoid Arthritis: Interim Analysis Results of a Phase 2, Open-Label Extension Study

被引：0
|
作者：
Strand, Vibeke [1 ]
Tundia, Namita [2 ]
Friedman, Alan [2 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
501
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Long-term safety of pirfenidone in RECAP, an open-label extension study in patients with idiopathic pulmonary fibrosis, interim results
    Costabel, Ulrich
    Albera, Carlo
    Fagan, Elizabeth
    Bradford, Williamson
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    Valeyre, Dominique
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [22] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB (ABT-494), AN ORAL JAK-1 INHIBITOR IN PATIENTS WITH RHEUMATOID ARTHRITIS IN AN OPEN-LABEL EXTENSION STUDY
    Genovese, Mark C.
    Kremer, Joel
    Zhong, Sheng
    Friedman, Alan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S85 - S85
  • [23] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [24] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2390 - I2392
  • [25] Clinical Outcomes for Rheumatoid Arthritis Patients Receiving Tofacitinib Monotherapy in the Open-Label Long-Term Extension over 6 Years
    Fleischmann, Roy
    Yazici, Yusuf
    Wollenhaupt, Juergen
    Wang, Lisy
    Maniccia, Anna
    Kwok, Kenneth
    Takiya, Liza
    van Vollenhoven, Ronald
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis
    Keystone, Ed
    Taylor, Peter
    Genovese, Mark
    Schlichting, Douglas
    de la Torre, Inmaculada
    Beattie, Scott
    Rooney, Terence
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1292 - 1292
  • [27] SAFETY AND EFFICACY OF BARICITINIB THROUGH 128 WEEKS IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Keystone, E.
    Taylor, P.
    Genovese, M.
    Schlichting, D.
    De La Torre, I
    Beattie, S.
    Rooney, T.
    Suters, A.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 26 - 26
  • [28] Long-term treatment with zonisamide: Results of a 2 year open-label extension study
    Wroe, S.
    Duncan, R.
    EPILEPSIA, 2006, 47 : 138 - 138
  • [29] An Interim Analysis Of Long-Term Outcomes In Patients Treated With Bosentan In The Double-Blind Or Open-Label Extension To The Early Trial
    Simonneau, G.
    Galie, N.
    Hoeper, M. M.
    Kusic-Pajic, A.
    Morganti, A.
    Rubin, L. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [30] AN INTERIM ANALYSIS OF LONG-TERM EXTENSION TRIALS OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    van Vollenhoven, R. F.
    Smolen, J. S.
    Tony, H. P.
    Codding, C.
    Keystone, E. C.
    Woodworth, T.
    Alecock, E.
    Alten, R.
    RHEUMATOLOGY, 2009, 48 : I86 - I87
12345